Top

International Ophthalmology

Published in:

26-07-2023 | Keratomileusis | Case Report

Development of interface haze after femtosecond laser-assisted in situ keratomileusis with accelerated corneal crosslinking: a case series

Authors: Hongbo Yin, Lixiang Wang, Rui Gong, Xiaolan Zhang, Ke Ma

Published in: International Ophthalmology | Issue 11/2023

Abstract

Background

Femtosecond laser-assisted in situ keratomileusis (FS-LASIK) with accelerated corneal crosslinking (FS-LASIK Xtra) is a recent procedure to achieve safer corneal ablation in myopic patients with borderline corneal thickness. Despite its well-accepted effectiveness, the development of remarkable interface haze is a potential concern but has rarely been reported and discussed.

Methods

We report for the first time a case series of 11 eyes of 7 patients who developed typical interface haze 1–3 months after FS-LASIK Xtra for the correction of myopia with astigmatism, with intensity grades ranging from 0.5 + to 3 + at the time of onset.

Results

The preclinical spherical diopters of the 7 patients ranged from − 2.25 D to − 9.25 D and cylindrical diopters ranged from − 0.25 D to − 2.50 D. The haze tended to be self-limiting, and topical anti-inflammatory therapy was given to moderate and severe cases, who responded well to treatment.

Conclusions

The development of clinically significant interface haze is a relatively rare complication after FS-LASIK Xtra but tends to have a higher incidence and intensity compared to conventional stromal surgery such as FS-LASIK. Timely treatment and close follow-up are essential to patients undertaking FS-LASIK Xtra.

Tomita M (2016) Combined laser in-situ keratomileusis and accelerated corneal cross-linking: an update. Curr Opin Ophthalmol 27(4):304–310. https://doi.org/10.1097/ICU.0000000000000281CrossRefPubMed

Xu W, Tao Y, Wang L et al (2017) Evaluation of biomechanical changes in myopia patients with unsatisfactory corneas after femto second-laser in situ keratomileusis (FS-LASIK) concurrent with accelerated corneal collagen cross-linking using corvis-ST: two-year follow-up results. Med Sci Monit 23:3649–3656. https://doi.org/10.12659/MSM.905493CrossRefPubMedPubMedCentral

Zhao L, Yin Y, Hu T et al (2023) Comprehensive management of post-LASIK ectasia: from prevention to treatment. Acta Ophthalmol. https://doi.org/10.1111/aos.15636CrossRefPubMed

Dong R, Zhang Y, Yuan Y et al (2022) A prospective randomized self-controlled study of LASIK combined with accelerated cross-linking for high myopia in Chinese: 24-month follow-up. BMC Ophthalmol 22(1):280. https://doi.org/10.1186/s12886-022-02491-yCrossRefPubMedPubMedCentral

Tan J, Lytle GE, Marshall J (2015) Consecutive laser in situ keratomileusis and accelerated corneal crosslinking in highly myopic patients: preliminary results. Eur J Ophthalmol 25(2):101–107. https://doi.org/10.5301/ejo.5000543CrossRef

Zhang J, Chen T, Wang J et al (2022) Laser in Situ Keratomileusis (LASIK) combined with prophylactic corneal cross-linking for correction of myopia: regional analysis of corneal morphology. Ophthalmol Ther 11(4):1423–1439. https://doi.org/10.1007/s40123-022-00510-1CrossRefPubMedPubMedCentral

Tamayo GE (2012) Predictable visual outcomes with accelerated corneal cross-linking concurrent with laser in situ keratomileusis. J Cataract Refract Surg 38(12):2206. https://doi.org/10.1016/j.jcrs.2012.10.023CrossRefPubMed

Lu NJ, Hafezi F, Torres-Netto EA et al (2023) Effect of fluence levels on prophylactic corneal cross-linking for laser in situ keratomileusis and transepithelial photorefractive keratectomy. Acta Ophthalmol 101(2):e185–e196. https://doi.org/10.1111/aos.15230CrossRefPubMed

Lim L, Lim EWL, Rosman M et al (2020) Three-year outcomes of simultaneous accelerated corneal crosslinking and femto-lasik for the treatment of high myopia in asian eyes. Clin Ophthalmol 14:2865–2872. https://doi.org/10.2147/OPTH.S260088CrossRefPubMedPubMedCentral

10.

Fantes FE, Hanna KD, Waring Iii GO et al (1990) Wound healing after excimer laser keratomileusis (photorefractive keratectomy) in monkeys. Arch Ophthalmol 108(5):665–675CrossRefPubMed

11.

Charpentier S, Keilani C, Maréchal M et al (2021) Corneal haze post photorefractive keratectomy. J Fr Ophtalmol 44(9):1425–1438. https://doi.org/10.1016/j.jfo.2021.05.006CrossRefPubMed

12.

Torricelli AA, Santhanam A, Wu J et al (2016) The corneal fibrosis response to epithelial-stromal injury. Exp Eye Res 142:110–118. https://doi.org/10.1016/j.exer.2014.09.012CrossRefPubMedPubMedCentral

13.

Wilson SE, Torricelli AAM, Marino GK (2020) Corneal epithelial basement membrane: structure, function and regeneration. Exp Eye Res 194:108002. https://doi.org/10.1016/j.exer.2020.108002CrossRefPubMedPubMedCentral

14.

Hafezi F, Hillen M, Kollros L et al (2022) Corneal cross-linking in thin corneas: from origins to state of the art. Eur Ophthalmic Rev 16(1):13–16. https://doi.org/10.17925/USOR.2022.16.1.13CrossRef

15.

Greenstein SA, Hersh PS (2021) Corneal crosslinking for progressive keratoconus and corneal ectasia: summary of US multicenter and subgroup clinical trials. Transl Vis Sci Technol 10(5):13. https://doi.org/10.1167/tvst.10.5.13CrossRefPubMedPubMedCentral

16.

Salomão MQ, Chaurasia SS, Sinha-Roy A et al (2011) Corneal wound healing after ultraviolet-A/riboflavin collagen cross-linking: a rabbit study. J Refract Surg 27(6):401–407. https://doi.org/10.3928/1081597x-20101201-02CrossRefPubMed

17.

Lim EWL, Lim L (2019) Review of laser vision correction (LASIK, PRK and SMILE) with simultaneous accelerated corneal crosslinking–long-term results. Curr Eye Res 44(11):1171–1180. https://doi.org/10.1080/02713683.2019.1656749CrossRefPubMed

18.

Marino GK, Santhiago MR, Torricelli AAM et al (2016) Corneal molecular and cellular biology for the refractive surgeon: the critical role of the epithelial basement membrane. J Refract Surg 32(2):118–125. https://doi.org/10.3928/1081597X-20160105-02CrossRefPubMedPubMedCentral

19.

Kymionis GD, Karavitaki AE, Portaliou DM et al (2010) Interface haze formation after ultra thin flap laser in situ keratomileusis. Ophthalmic Surg Lasers Imaging. https://doi.org/10.3928/15428877-20100215-66CrossRefPubMed

20.

Esquenazi S, He J, Li N et al (2010) Immunofluorescence of rabbit corneas after collagen cross-linking treatment with riboflavin and ultraviolet A. Cornea 29(4):412–417. https://doi.org/10.1097/ICO.0b013e3181bdf1ccCrossRefPubMedPubMedCentral

21.

Covre J, Cristovam P, Loureiro R et al (2013) Evaluation of the riboflavin and ultraviolet light effect on keratocytes cultivated in vitro. Investig Ophthalmol Vis Sci 54(15):1021

22.

Margo JA, Munir WM (2016) Corneal haze following refractive surgery: A review of pathophysiology, incidence, prevention, and treatment. Int Ophthalmol Clin 56(2):111–125. https://doi.org/10.1097/IIO.0000000000000112CrossRefPubMed

23.

Furukawa H, Nakayasu K, Gotoh T et al (1997) Effect of topical tranilast and corticosteroids on subepithelial haze after photorefractive keratectomy in rabbits. J Refract Surg 13(5):S457–S458CrossRefPubMed

24.

Pakbin M, Khabazkhoob M, Pakravan M et al (2020) Duration of topical steroid application after photorefractive keratectomy with mitomycin C. J Cataract Refract Surg 46(4):622–632. https://doi.org/10.1097/j.jcrs.0000000000000060CrossRefPubMed

25.

Gartry DS, Muir MGK, Lohmann CP et al (1992) The effect of topical corticosteroids on refractive outcome and corneal haze after photorefractive keratectomy: a prospective, randomized, double-blind trial. Arch Ophthalmol 110(7):944–952CrossRefPubMed

26.

Aras C, Özdamar A, Aktunç R et al (1998) The effects of topical steroids on refractive outcome and corneal haze ,thickness, and curvature after photorefractive keratectomy with a 6.0-mm ablation diameter. Ophthalmic Surg Lasers 29(8):621–627CrossRefPubMed

27.

Soya K, Obata H, Amano S et al (1997) Effects of topical corticosteroids on subepithelial haze after excimer laser corneal surgery objective and quantitative method for evaluating haze. J Jpn Ophthalmol Soc 101(2):152–157

28.

Zhang X, Shen Z, Sun H et al (2023) Efficacy and safety of loteprednol etabonate versus fluorometholone in the treatment of patients after corneal refractive surgery: a meta-analysis. Int Ophthalmol. https://doi.org/10.1007/s10792-023-02646-wCrossRefPubMedPubMedCentral

Title: Development of interface haze after femtosecond laser-assisted in situ keratomileusis with accelerated corneal crosslinking: a case series
Authors: Hongbo Yin
Lixiang Wang
Rui Gong
Xiaolan Zhang
Ke Ma
Publication date: 26-07-2023
Publisher: Springer Netherlands
Keywords: Keratomileusis
Refractive Surgery
Laser
Published in: International Ophthalmology / Issue 11/2023
Print ISSN: 0165-5701
Electronic ISSN: 1573-2630
DOI: https://doi.org/10.1007/s10792-023-02800-4

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Development of interface haze after femtosecond laser-assisted in situ keratomileusis with accelerated corneal crosslinking: a case series

Abstract

Background

Methods

Results

Conclusions

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Background

Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 11/2023

Changes of dysfunctional lens index before and after implantable collamer lens V4c implantation in patients with moderate-to-high myopia

The evaluation of the skin-muscle and only-skin upper blepharoplasty featuring surface electromyography: a single-masked, randomized split-face prospective study

The efficacy of 2 different phakic intraocular lens implant in keratoconus as an isolated procedure or combined with collagen crosslinking and intra-stromal corneal ring segments: a systematic review and meta-analysis

Atomic force microscopy for the evaluation of corneal surface roughness after femtosecond laser flap creation and excimer ablation

Management of external ocular prosthesis by ocularists: results of an online survey conducted in Brazil and Spain

Intravitreal fluocinolone acetonide 0.19 mg (ILUVIEN®) in patients with non-infectious uveitis: real-world effectiveness and safety outcomes at 12 months